Patents by Inventor Dexter Cameron Davis

Dexter Cameron Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sesquiterpenoid analogs
    Patent number: 11814396
    Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: November 14, 2023
    Assignees: Purdue Research Foundation, University of Florida Research Foundation, Inc.
    Inventors: Mingji Dai, Dexter Cameron Davis, Alexander Adibekian, Dominic Gregor Hoch, Zhong-Yin Zhang
  • Sesquiterpenoid analogs
    Patent number: 11518770
    Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: December 6, 2022
    Assignees: Purdue Research Foundation, University of Florida Research Foundation, Inc.
    Inventors: Mingji Dai, Dexter Cameron Davis, Alexander Adibekian, Dominic Gregor Hoch, Zhong-Yin Zhang
  • Aryl isonitriles as a new class of antimicrobial compounds
    Patent number: 11198674
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: December 14, 2021
    Assignee: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • NOVEL SESQUITERPENOID ANALOGS
    Publication number: 20210261565
    Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging thugs for cancers.
    Type: Application
    Filed: May 3, 2021
    Publication date: August 26, 2021
    Applicant: Purdue Research Foundation
    Inventors: Mingji Dai, Dexter Cameron Davis, Alexander Adibekian, Dominic Gregor Hoch, Zhong-Yin Zhang
  • Aryl isonitriles as a new class of antimicrobial compounds
    Patent number: 11098014
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: August 24, 2021
    Assignee: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • Aryl isonitriles as a new class of antimicrobial compounds
    Patent number: 11091437
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: August 17, 2021
    Assignee: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • NOVEL SESQUITERPENOID ANALOGS
    Publication number: 20200040000
    Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.
    Type: Application
    Filed: August 5, 2019
    Publication date: February 6, 2020
    Applicant: Purdue Research Foundation
    Inventors: Mingji Dai, Dexter Cameron Davis, Alexander Adibekian, Dominic Gregor Hoch, Zhong-Yin Zhang
  • ARYL ISONITRILES AS A NEW CLASS OF ANTIMICROBIAL COMPOUNDS
    Publication number: 20190352264
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Application
    Filed: July 15, 2019
    Publication date: November 21, 2019
    Applicant: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • ARYL ISONITRILES AS A NEW CLASS OF ANTIMICROBIAL COMPOUNDS
    Publication number: 20190352265
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Application
    Filed: July 15, 2019
    Publication date: November 21, 2019
    Applicant: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • ARYL ISONITRILES AS A NEW CLASS OF ANTIMICROBIAL COMPOUNDS
    Publication number: 20190330154
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Application
    Filed: June 18, 2019
    Publication date: October 31, 2019
    Applicant: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • Aryl isonitriles as a new class of antimicrobial compounds
    Patent number: 10364224
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: July 30, 2019
    Assignee: Purdue Research Foundation
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad
  • ARYL ISONITRILES AS A NEW CLASS OF ANTIMICROBIAL COMPOUNDS
    Publication number: 20160287550
    Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.
    Type: Application
    Filed: April 4, 2016
    Publication date: October 6, 2016
    Inventors: Mohamed Seleem, Mingji Dai, Dexter Cameron Davis, Haroon Taj Mohammad